bloating while on semaglutide Wegovy Bloating: Why It Occurs and How to Manage It Ozempic (Semaglutide): GLP-1 receptor agonist

However, restarting the medication is not recommended if you are nursing

One day you get 0.3mg, the next you get 1.7mg

Additionally, some patients may experience weight loss, which can further aid in managing diabetes and improving overall health

Food and Drug Administration (FDA): Ozempic (semaglutide) Injection Prescribing Information National Institutes of Health (NIH): Gastrointestinal Side Effects of GLP-1 Receptor Agonists and Clinical Management The New England Journal of Medicine (NEJM): Effects of Semaglutide on Chronic Kidney Disease Progression in Patients with Type 2 Diabetes (The FLOW Trial) American Diabetes Association (ADA): Standards of Care in DiabetesMetabolic Strategies and Renal Safety Profile of Incretin-Based Therapies National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Understanding Acute Kidney Injury: Causes, Risks, and Fluid Balance Protocols

Tesamorelin and GLP-1 medications work on entirely different pathways and can be discussed at the intake as complementary or alternative options depending on the patients goals and history

UK Clinical Guidance Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management, but many patients wonder about its effects on existing bowel conditions